CD4+ T-lymphocyte count <100 cells/µl

Slides:



Advertisements
Similar presentations
Excellent healthcare – locally delivered What’s new in the diagnosis, prevention and management of HIV-related cryptococcal disease Nelesh Govender (on.
Advertisements

Fungal Infections in HIV-patients
The South African Cryptococcal Screening Program: Program update XIX international AIDS Conference Washington United States 24 th July 2012 Dr. Samuel.
Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.
Ois generalPCPCryptococcus-Toxoplasma
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.
Cryptococcal Meningitis in Patients with AIDS. Clinical Case 30-year-old male with AIDS CD4 25 cells/mm3 Gradual increasing headache for past five days.
Cryptococcal Screening- Laboratory perspective and considerations in South Africa and sub-Saharan Africa Prof W. Stevens Head Department Molecular Medicine.
Screen-and-Treat A new strategy to prevent cryptococcal deaths.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
CASE 1 55 yo man…Baker HIV+ since 1996 Refused bloodwork over the years as was ‘Feeling fine’ Oral hairy leukoplakia noted on oral biopsy in 2001.
Evaluation of a Novel Point of Care Cryptococcal Antigen (CRAG) Test on Serum, Plasma and Urine from Patients with HIV-associated Cryptococcal Meningitis.
IAS–USA When to Start Antiretroviral Therapy Constance A. Benson, MD Professor of Medicine University of California San Diego FINAL: Presented.
JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.
COST-BENEFIT OF INTEGRATING CRYPTOCOCCAL ANTIGEN SCREENING AND PREEMPTIVE TREATMENT INTO ROUTINE HIV CARE Radha Rajasingham, David Meya, Melissa Rolfes,
Cryptococcal Meningitis Dr N Thumbiran Infectious Diseases Department UKZN.
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Prattana Leenasirimakul
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Coccidioidomycosis Slide Set Prepared by the.
NYU Medical Grand Rounds Clinical Vignette Mark H. Adelman, M.D. PGY-2 2/19/13 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Clinical and mycological determinants of Cryptococcosis-associated IRIS (C-IRIS) Chang CC, Elliott JE, Gosnell BI, Dorasamy AA, Omarjee S, Naranbhai V,
Cryptococcal Antigen Screening in Uganda David R Boulware MD MPH Radha Rajasingham MD David B Meya MMed Infectious Disease Institute Makerere University.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Cryptococcosis Slide Set Prepared by the AETC.
Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
CNS fungal infections. Fungal infections Cryptococcal meningitis (AIDS) Candida meningitis (neonates and neurosurgery) Brain abscesses.
Complex OIs of the CNS David R Boulware MD, MPH, CTropMed Lois & Richard King Distinguished Assoc. Professor University of Minnesota
Spider Bite John W. Baddley, MD, MSPH University of Alabama at Birmingham Birmingham VA Medical Cent er.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection The INSIGHT START Study Group Ben Andres Oct 15, 2015.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, National Institutes of Health, and HIV Medicine Association/Infectious.
Dr Angela Loyse CI Dr Sayoki Mfinanga PI-National Institute Medical Research Tanzania Dr Cecilia Kanyama PI-UNC Project Malawi Dr Charles Kouanfack PI-Hôpital.
Spinraza™ - Nusinersen
The Changing Face of Advanced Disease
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Histoplasmosis Slide Set Prepared by the AETC.
CHILDREN and HIV.
Management of the Newborn When Maternal TB Suspected
Amir Shroufi Medical Coordinator MSF South Africa
Presented to the AIDS 2016 Conference
HIV in pregnancy ESMOE.
Infant born with mother Tuberculosis
Indeterminate and inconclusive results are common when using Interferon Gamma Release Assay as screening for TB in patients with IBD Nasr I, Goel RM, Ward.
Copyright © 2010 American Medical Association. All rights reserved.
Implementing CRAG Screening among HIV Patients Initiating ART in Rural HIV Clinics with Regular Absence of CD4 Testing Services in Tanzania Gladys Mbwanji.
Treatment of Latent TB Infection (LTBI)
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS
Dr Lindi Coetzee Ms Keshendree Moodley Prof D.K. Glencross
Patients w/AIDS-defining illness
HIV Opportunistic infections
Meningitis Surveillance and investigation of causes of altered mental status among Kamuzu Central Hospital admissions, Lilongwe, Malawi Charles Kyriakos.
Figure 4 Host damage from infection-related inflammatory
Figure 2 Systemic immune responses to cryptococcal antigen
Cryptococcosis: Treatment outcome
CrAg titers- To know or not to know
Nat. Rev. Neurol. doi: /nrneurol
Figure 5 Corticosteroid treatment can reduce brain
Disseminated Histoplasmosis Treated with Amphotericin B
Cryptococcal Immune Reconstitution Inflammatory Syndrome
بنام خداوند جان و خرد بنام خداوند جان و خرد.
Meningitis.
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Paul E. Klapper, Graham M. Cleator  Clinical.
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
CLINICAL PROBLEM SOLVING
Cryptococcosis: Treatment outcome
Daily nocturnal home hemodialysis
Figure 2 Evolution of blood cell counts during interleukin (IL)–7 therapy Evolution of blood cell counts during interleukin (IL)–7 therapy The leukocyte.
5th edition NTP MANUAL OF PROCEDURES Case Finding
Presentation transcript:

CD4+ T-lymphocyte count <100 cells/µl Cryptococcal antigen screening when CD4+ T-lymphocyte count <100 cells/µl Initiate ART No fluconazole NEGATIVE POSITIVE Contact patient for urgent follow-up Screen for symptoms of meningitis* Check for special situations† *Symptomatic for meningitis if either of the following is present: Headache Confusion Symptomatic Asymptomatic§ †Special situations include: Prior cryptococcal meningitis Pregnancy or breastfeeding mothers Clinical liver disease Start fluconazole 1200 mg daily and refer immediately for lumbar puncture §A lumbar puncture may be considered if available. Lumbar puncture (+) Lumbar puncture (-) Amphotericin B plus fluconazole 800 mg daily for 2 weeks in hospital Fluconazole 800 mg daily for 2 weeks as outpatient FIGURE 1: Screen-and-treat algorithm for ART-naïve adult patients with CD4+ T-lymphocyte count <100 cells/µl Fluconazole 400 mg daily for 2 months then 200 mg daily Continue fluconazole for minimum of 1 year in total and discontinue when patient has had two CD4 counts >200 taken at least 6 months apart Start ART after 4-6 weeks of antifungal therapy  Start ART after 2 weeks of antifungal therapy 

FIGURE 2: Laboratory procedure to set up and read the cryptococcal antigen lateral flow assay (Immuno-Mycologics, Norman, OK) Source: Immy CrAg LFA package insert (reprinted with permission from Immy)